Saluda Medical

Saluda Medical is a global neuromodulation company leading the development and commercialization of data-driven, personalized therapies for patients with chronic pain. The company’s first product, Evoke®, is a closed-loop spinal cord stimulator (SCS) system designed to treat chronic pain, a condition that affects more than 540 million people globally. SCS treats the condition by stimulating the spinal cord and altering the transmission of pain signals to the brain. Evoke is designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then makes millions of real-time adjustments per day to maintain a consistent level of therapy. In the EU, Evoke is CE Marked and commercially available. In the U.S., Evoke is currently under investigation through the first double-blinded, randomized, controlled U.S. pivotal study in SCS and is not commercially available. Saluda Medical is a privately held company with headquarters in Artarmon, New South Wales, Australia and has offices in Bloomington, MN, USA and Harrogate, UK. CAUTION: The Evoke Spinal Cord Stimulator is an investigational device in the United States and is limited by Federal (or United States) law to investigational use. These products are not yet approved for marketing or for sale in any geography.